Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 11,701-11,712 of 23,847
Drug study icon
Active Not RecruitingNCT05838560

Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders

This study is looking at whether a digital support tool can help people with Schizophrenia, Treatment Resistant Depression, or Aging, Premature. Participants receive a study treatment and complete follow-up visits and assessments.

In St Louis
Depression, SchizophreniaDrugA study involving a medication or substance.Over 50 Years
Countries
United States
Sponsor
Washington University School of Medicine
Condition
Depression, Schizophrenia
Drug study icon
CompletedNCT02276209

Dasotraline Adult ADHD Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Phoenix
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT02684279

Dasotraline Binge Eating disorders Extension Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Eating disordersDrugFrom 18 Years to 56 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Eating disorders
Drug study icon
CompletedNCT02564588

Dasotraline Binge Eating disorders Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Beverly Hills
Eating disordersDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
Eating disorders
Drug study icon
CompletedNCT02428088

Dasotraline Pediatric ADHD Study

This study exists to understand whether a medication treatment is both safe enough and useful enough to take further. Researchers are trying to understand whether a medication treatment can give earlier or clearer feedback during care.

Multiple locations, including Dothan
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT02457819

Dasotraline Pediatric Extension Study

This study exists to understand how a medication treatment holds up over time after the earliest research stage. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Dothan
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Drug study icon
CompletedNCT02195167

Dasotraline SEP360-105 Pediatric PK/PD Study

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

Multiple locations, including Little Rock
ADHDDrugFrom 6 Years to 17 Years
Countries
United States
Sponsor
Sumitomo Pharma America, Inc.
Condition
ADHD
Other study type icon
CompletedNCT03833804

Data-driven Identification for Substance Misuse

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
AddictionOtherFrom 18 Years to 89 Years
Countries
United States
Sponsor
University of Wisconsin, Madison
Condition
Addiction
Drug study icon
TerminatedNCT02623504

DB/Maintenance of Equetro (Carbamazepine) in Children With Acute Manic or Mixed Bipolarity type I

This study exists to understand how blood tests and biological markers holds up over time after the earliest research stage. Researchers are trying to understand whether blood tests and biological markers can improve sleep, daily rhythms, and longer-term stability.

Multiple locations, including Orlando
BipolarityDrugFrom 10 Years to 17 Years
Countries
United States
Sponsor
Validus Pharmaceuticals
Condition
Bipolarity
Device study icon
Active Not RecruitingNCT04106466

DBS for TRD With the Medtronic Summit RC+S

This observational study is following people with depression or Treatment Resistant Depression to understand outcomes over time. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In New York
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 25 Years to 70 Years
Countries
United States
Sponsor
Helen Mayberg, MD
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.